HUP0104162A2 - Katechinszármazékok alkalmazása proteináz-inhibitor hatású gyógyszerkészítmények előállítására - Google Patents
Katechinszármazékok alkalmazása proteináz-inhibitor hatású gyógyszerkészítmények előállításáraInfo
- Publication number
- HUP0104162A2 HUP0104162A2 HU0104162A HUP0104162A HUP0104162A2 HU P0104162 A2 HUP0104162 A2 HU P0104162A2 HU 0104162 A HU0104162 A HU 0104162A HU P0104162 A HUP0104162 A HU P0104162A HU P0104162 A2 HUP0104162 A2 HU P0104162A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- heterocyclic
- aryl
- hydrogen atom
- atom
- Prior art date
Links
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 formyl- Chemical group 0.000 abstract 9
- 125000003118 aryl group Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 229910052799 carbon Inorganic materials 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- 150000001721 carbon Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001766 catechin derivatives Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 235000019833 protease Nutrition 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány (I) általános képletű katechin-származékok (mely képletbenR1 jelentése hidrogénatom, aril-heterociklikus-, 1-16 szénatomosalkil-, aril-, formil-, N,N-dimetil-karbamoil-, acetil-, CO-tercierbutil-, heterociklikus- vagy 2-16 szénatomos alkenilcsoport; R2jelentése hidrogénatom, aril-heterociklikus-, 1-16 szénatomos alkil-,aril-, formil-, N,N-dimetil-karbamoil-, acetil-, CO-tercier butil-,heterociklikus- vagy 2-16 szénatomos alkenil-csoport; R3 jelentésehidrogénatom, hidroxil-, 2-16 szénatomos alkoxi- vagy 2-6 szénatomos-alkenil-COO-1-6 szénatomos alkilcsoport; R4 jelentése aril-, -CH=CH-arilcsoport, hidrogénatom, helyettesítetlen vagy hidroxilcsoporttal,aminocsoporttal és/vagy halogénatommal helyettesített 2-16 szénatomosmono- vagy dialkinilcsoport, heterociklikus-, -C(O)-heterociklikus-vagy 1-8 szénatomos alkilcsoport; vagy R3 és R4 az aromás gyűrűszéntomjaival együtt 4-6-tagú telített vagy részben telítetlenciklikus szénhidrogén-gyűrűt képez; és R5 jelentése aril-, -CH=CH-arilcsoport, hidrogénatom, helyettesítetlen vagy hidroxilcsoporttal,aminocsoporttal és/vagy halogénatommal helyettesített 2-16 szénatomosmono- vagy dialkinilcsoport, heterociklikus-, -C(O)-heterociklikus-vagy 1-8 szénatomos alkilcsoport; vagy R4 és R5 az aromás gyűrűszénatomjaival együtt 4-6-tagú, telített vagy részben telítetlenciklikus szénhidrogén-gyűrűt képez) és gyógyászatilag alkalmas sóikalkalmazására vonatkozik proteináz inhibitor hatásúgyógyszerkészítmények előállítására. Ó
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19845372A DE19845372A1 (de) | 1998-10-02 | 1998-10-02 | Verwendung von Katecholderivaten als Proteinaseninhibitoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0104162A2 true HUP0104162A2 (hu) | 2002-05-29 |
| HUP0104162A3 HUP0104162A3 (en) | 2002-08-28 |
Family
ID=7883162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104162A HUP0104162A3 (en) | 1998-10-02 | 1999-09-23 | Use of catechol derivatives for producing pharmaceutical compositions having proteinase inhibitor effect |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6509368B1 (hu) |
| EP (1) | EP1119351B1 (hu) |
| JP (1) | JP2002526404A (hu) |
| AT (1) | ATE238781T1 (hu) |
| AU (1) | AU766379B2 (hu) |
| CA (1) | CA2346019A1 (hu) |
| DE (2) | DE19845372A1 (hu) |
| DK (1) | DK1119351T3 (hu) |
| ES (1) | ES2198992T3 (hu) |
| HK (1) | HK1039451B (hu) |
| HU (1) | HUP0104162A3 (hu) |
| NZ (1) | NZ510820A (hu) |
| PT (1) | PT1119351E (hu) |
| WO (1) | WO2000019989A2 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003009807A2 (en) | 2001-07-23 | 2003-02-06 | Galileo Laboratories, Inc. | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4490464A (en) * | 1981-04-08 | 1984-12-25 | Gorton Lo G | Electrode for the electrochemical regeneration of coenzyme, a method of making said electrode, and the use thereof |
| DE3518655A1 (de) * | 1985-05-24 | 1986-11-27 | Grünenthal GmbH, 5190 Stolberg | Neue phenolderivate, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel |
| WO1988001509A1 (en) * | 1986-08-25 | 1988-03-10 | Chemex Pharmaceuticals, Inc. | Pharmacologically active compositions of catecholic butanes with zinc |
| US5409690A (en) * | 1993-06-23 | 1995-04-25 | Chemex Pharmaceuticals, Inc. | Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol |
| WO1996031206A2 (en) * | 1995-04-07 | 1996-10-10 | Warner-Lambert Company | Flavones and coumarins as agents for the treatment of atherosclerosis |
| EP0850055B1 (en) * | 1995-09-11 | 2005-06-29 | Osteoarthritis Sciences, Inc. | Protein tyrosine kinase inhibitors for treating osteoarthritis |
| AU8742198A (en) * | 1997-08-15 | 1999-03-08 | Shire International Licensing B.V. | Use of cholinesterase inhibitor for treating diseases associated with pro teolytic enzyme activity |
| JP2886523B1 (ja) * | 1998-01-20 | 1999-04-26 | 岐阜県 | ガン転移抑制剤及びコラゲナーゼ活性抑制剤 |
-
1998
- 1998-10-02 DE DE19845372A patent/DE19845372A1/de not_active Ceased
-
1999
- 1999-09-23 DK DK99969932T patent/DK1119351T3/da active
- 1999-09-23 PT PT99969932T patent/PT1119351E/pt unknown
- 1999-09-23 AT AT99969932T patent/ATE238781T1/de not_active IP Right Cessation
- 1999-09-23 NZ NZ510820A patent/NZ510820A/en unknown
- 1999-09-23 EP EP99969932A patent/EP1119351B1/de not_active Expired - Lifetime
- 1999-09-23 US US09/806,466 patent/US6509368B1/en not_active Expired - Fee Related
- 1999-09-23 ES ES99969932T patent/ES2198992T3/es not_active Expired - Lifetime
- 1999-09-23 DE DE59905355T patent/DE59905355D1/de not_active Expired - Fee Related
- 1999-09-23 AU AU59813/99A patent/AU766379B2/en not_active Ceased
- 1999-09-23 WO PCT/EP1999/007068 patent/WO2000019989A2/de active IP Right Grant
- 1999-09-23 JP JP2000573350A patent/JP2002526404A/ja not_active Withdrawn
- 1999-09-23 HU HU0104162A patent/HUP0104162A3/hu unknown
- 1999-09-23 CA CA002346019A patent/CA2346019A1/en not_active Abandoned
-
2002
- 2002-01-29 HK HK02100704.5A patent/HK1039451B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1039451B (zh) | 2003-08-22 |
| DE19845372A1 (de) | 2000-04-20 |
| EP1119351A2 (de) | 2001-08-01 |
| DE59905355D1 (de) | 2003-06-05 |
| ATE238781T1 (de) | 2003-05-15 |
| EP1119351B1 (de) | 2003-05-02 |
| ES2198992T3 (es) | 2004-02-01 |
| HK1039451A1 (en) | 2002-04-26 |
| HUP0104162A3 (en) | 2002-08-28 |
| JP2002526404A (ja) | 2002-08-20 |
| AU5981399A (en) | 2000-04-26 |
| WO2000019989A2 (de) | 2000-04-13 |
| DK1119351T3 (da) | 2003-08-18 |
| CA2346019A1 (en) | 2000-04-13 |
| US6509368B1 (en) | 2003-01-21 |
| PT1119351E (pt) | 2003-09-30 |
| WO2000019989A3 (de) | 2000-11-09 |
| AU766379B2 (en) | 2003-10-16 |
| NZ510820A (en) | 2004-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1105162T1 (el) | Ενωσεις και η χρηση τους ως αναστολεις 5-ητ | |
| BRPI0718966B8 (pt) | composto, composição farmacêutica, inibidor plk1 e agente antitumoral | |
| HUP0303756A2 (hu) | 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0302167A2 (hu) | Metabotropikus glutamát receptor antagonista hatású kinolinszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
| HUP0301311A2 (hu) | N-oxidok mint 4-fenil-piridin-származékok előgyógyszerei, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| BRPI0509588A (pt) | derivados e tetraidronaftiridina e um processo para preparação dos mesmos | |
| AR046200A1 (es) | Derivados de pirazina y su uso farmaceutico. procesos de preparacion y composiciones farmaceuticas | |
| HUP0203548A2 (hu) | Új spirooxindolszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| EP2017278A4 (en) | DIHYDROPYRAZOLOPYRIMIDINONDERIVAT | |
| CR9314A (es) | Derivado de espirocetal y uso del mismo como medicina para la diabetes | |
| BRPI0414450A (pt) | derivados de diazabicicloalcano substituìdos como ligandos nos receptores de alfa 7 acetilcolina nicotìnica | |
| CY1105784T1 (el) | Εκδοχα της πιπepαζινυλακυλπιπepιδινης η παρασκευη τους και η εφαρμογη τους στη θepαπευτικη | |
| HRP20050213A2 (en) | 2,4-substituted indoles and their use as 5-ht6 modulators | |
| BRPI0213393B8 (pt) | derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica | |
| MX2010000658A (es) | Derivados de pirimidina 934. | |
| UA90483C2 (uk) | Похідні n-(1н-індоліл)-1н-індол-2-карбоксамідів, їх отримання і їх застосування в терапії | |
| CY1111517T1 (el) | Παραγωγα 1,3-δ1υδροιμιδαζολο-2-θειονης ως αναστολεις της ντοπαμινης-βητα-υδροξυλασης | |
| HUP0203184A2 (hu) | Izoxazolkarboxamid-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| UA101162C2 (ru) | Производные индол-2-она, двузамещенные в положении 3, их получение и применение в терапии | |
| BRPI0517100A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, método para preparar um composto, composição farmacêutica, e, métodos para tratar um paciente sofrendo de distúrbios e de deficiência | |
| MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
| HUP9700708A2 (hu) | N-[(9-pirimido[1,2-a]indolil)-metil-fenil-acetil]-fenil-glicinol-származékok, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és intermedierjeik | |
| BRPI0414460A (pt) | compostos derivados de carboxamida do tipo de amida, composição farmacêutica e respectivo uso | |
| HUP0100785A2 (hu) | Indolszármazékok, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyászati készítmények | |
| HUP0104162A2 (hu) | Katechinszármazékok alkalmazása proteináz-inhibitor hatású gyógyszerkészítmények előállítására |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |